Interleukin-4 and 13 concentrations in infants at risk to develop bronchopulmonary dysplasia

BMC Pediatrics

Volumn 3, Issue , 2003, Pages

  Baier, R John ^a   Loggins, John ^b   Kruger, Thomas E ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 13; INTERLEUKIN 4; LUNG SURFACTANT; OXYGEN;

ARTICLE; ASPIRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; LOW BIRTH WEIGHT; LUNG DYSPLASIA; PATHOGENESIS; PREMATURITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; TRACHEA; BODY FLUID; IMMUNOLOGY; METABOLISM; NEWBORN; VERY LOW BIRTH WEIGHT;

BODY FLUIDS; BRONCHOPULMONARY DYSPLASIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; INTERLEUKIN-13; INTERLEUKIN-4; PROSPECTIVE STUDIES; TRACHEA;

EID: 2642515678     PISSN: 14712431     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2431-3-8     Document Type: Article

References (38)

1. Merritt TA, Stuard ID, Puccia J, Wood B, Edwards DK, Finkelstein J and Shapiro DL: Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 1981, 98:949-956.
2. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H and Speer CP: Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994, 93:712-718.
3. Murch SH, Costeloe K, Klein NJ and MacDonald TT: Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 1996, 40:490-497.
4. Jonsson B, Tullus K, Brauner A, Lu Y and Noack G: Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997, 77:F198-201.
5. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B and Brauner A: Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996, 155:112-116.
6. Groneck P and Speer CP: Interleukin-8 in pulmonary effluent fluid of preterm infants. J Pediatr 1993, 123:839-840.
7. Kotecha S, Wilson L, Wangoo A, Silverman M and Shaw RJ: Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996, 40:250-256.
8. Munshi UK, Niu JO, Siddiq MM and Parton LA: Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997, 24:331-336.
9. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P and deLemos RA: Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996, 39:966-975.
10. Thomson Angus W.: The cytokine handbook. 3rdth edition. San Diego, Academic Press; 1998:xxii, 1017 p..
11. Kucharzik T, Lugering N, Pauels HG, Domschke W and Stoll R: IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells. Clin Exp Immunol 1998, 111:152-157.
12. Yano S, Yanagawa H, Nishioka Y, Mukaida N, Matsushima K and Sone S: T helper 2 cytokines differently regulate monocyte chemoattractant protein-1 production by human peripheral blood monocytes and alveolar macrophages. J Immunol 1996, 157:2660-2665.
13. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K and Kunkel SL: IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 1990, 145:1435-1439.
14. de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G and de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993, 151:6370-6381.
15. Wang P, Wu P, Siegel MI, Egan RW and Billah MM: Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270:9558-9563.
16. Goebeler M, Schnarr B, Toksoy A, Kunz M, Brocker EB, Duschl A and Gillitzer R: Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation. Immunology 1997, 91:450-457.
17. Kim C, Schinkel C, Fuchs D, Stadler J, Walz A, Zedler S, von Donnersmarck GH and Faist E: Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress. Arch Surg 1995, 130:1330-1336.
18. Mulligan MS, Warner RL, Foreback JL, Shanley TP and Ward PA: Protective effects of IL-4, IL-10, IL-12, and IL-13 in IgG immune complex-induced lung injury: role of endogenous IL-12. J Immunol 1997, 159:3483-3489.
19. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL and Donaldson DD: Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258-2261.
20. Wong WS and Koh DS: Advances in immunopharmacology of asthma. Biochem Pharmacol 2000, 59:1323-1335.
21. Northway W. H., Jr., Rosan RC and Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967, 276:357-368.
22. Bancalari E, Abdenour GE, Feller R and Gannon J: Bronchopulmonary dysplasia: clinical presentation. J Pediatr 1979, 95:819-823.
23. Shennan AT, Dunn MS, Ohlsson A, Lennox K and Hoskins EM: Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988, 82:527-532.
24. Palta M, Sadek M, Barnet JH, Evans M, Weinstein MR, McGuinness G, Peters ME, Gabbert D, Fryback D and Farrell P: Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project. J Pediatr 1998, 132:57-63.
25. Jobe AH and Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001, 163:1723-1729.
26. Baier RJ, Loggins J and Kruger TE: Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Investig Med 2001, 49:362-369.
27. Watts CL and Bruce MC: Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants. J Pediatr 1995, 127:113-122.
28. Chen X, Gavett SH and Wills-Karp M: CD4+ T lymphocyte modulation of ozone-induced murine pulmonary inflammation. Am J Respir Cell Mol Biol 1995, 12:396-403.
29. Buttner C, Skupin A, Reimann T, Rieber EP, Unteregger G, Geyer P and Frank KH: Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol 1997, 17:315-325.
30. Nakamura Y, Azuma M, Okano Y, Sano T, Takahashi T, Ohmoto Y and Sone S: Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol 1996, 15:680-687.
31. Sempowski GD, Beckmann MP, Derdak S and Phipps RP: Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994, 152:3606-3614.
32. Sempowski GD, Derdak S and Phipps RP: Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996, 167:290-296.
33. Hancock A, Armstrong L, Gama R and Millar A: Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung. Am J Respir Cell Mol Biol 1998, 18:60-65.
34. Tang ML and Kemp AS: Ontogeny of IL4 production. Pediatr Allergy Immunol 1995, 6:11-19.
35. Cassell GH, Waites KB, Crouse DT, Rudd PT, Canupp KC, Stagno S and Cutter GR: Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet 1988, 2:240-245.
36. Wang EE, Frayha H, Watts J, Hammerberg O, Chernesky MA, Mahony JB and Cassell GH: Role of Ureaplasma urealyticum and other pathogens in the development of chronic lung disease of prematurity. Pediatr Infect Dis J 1988, 7:547-551.
37. Wang EE, Ohlsson A and Kellner JD: Association of Ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a metaanalysis. J Pediatr 1995, 127:640-644.
38. So EY, Kim SH, Park HH, Cho BS and Lee CE: Corticosteroid inhibits IL-4 signaling through down-regulation of IL-4 receptor and STAT6 activity. FEBS Lett 2002, 518:53-59.